Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the national cancer data base

Journal of Thoracic Oncology

Volumn 10, Issue 2, 2015, Pages 316-323

  Combs, Susan E ^a   Hancock, Jacquelyn G ^a   Boffa, Daniel J ^a   Decker, Roy H ^a   Detterbeck, Frank C ^a   Kim, Anthony W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Lobectomy; Radiation therapy; Small cell lung cancer; Sublobar resection; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL CELL LUNG CANCER; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; SMALL CELL LUNG CARCINOMA; SURVIVAL; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84922334966     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000402     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures. 2010. Atlanta: American Cancer Society, 2010
2. van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet 2011;378:1741-1755
3. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618-1624
4. Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with oncedaily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-271
5. Fox W, Scadding JG. Treatment of oat-celled carcinoma of the bronchus. Lancet 1973;2:616-617
6. Lad T, Piantadosi S, Thomas P, et al. A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest 1994; 106:320S-323S.
7. Eberhardt W, Stamatis G, Stuschke M, et al. Prognostically orientated multimodality treatment including surgery for selected patients of smallcell lung cancer patients stages IB to IIIB: Long-term results of a phase II trial. Br J Cancer 1999;81:1206-1212
8. Jett JR, Schild SE, Kesler KA, et al. Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143:e400S-e419S.
9. National Cancer Data Base. http://www.facs.org/cancer/ncdb/index.html. Accessed January 14, 2014
10. Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: A powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008;15:683-690
11. Commission on Cancer. Facility Oncology Registry Data Standards (FORDS): Revised for 2012. Chicago: American College of Surgeons Commission on Cancer; 2002
12. Collaborative Stage Work Group of the American Joint Committee on Cancer. Collaborative Stage Data Collection System User Documentation and Coding Instructions, Version 02.04.40. Published by American Joint Committee on Cancer. Chicago, IL.
13. Jänne PA, Freidlin B, Saxman S, et al. Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America. Cancer 2002;95:1528-1538
14. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-4544
15. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2:706-714.
16. Lüchtenborg M, Riaz SP, Lim E, et al. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009. Thorax 2014;69:269-273
17. Kalemkerian GP, Akerley W, Bogner P, et al. Small cell lung cancer. J Natl Compr Canc Netw 2013; 11:78-98
18. Yu JB, Decker RH, Detterbeck FC, et al. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010; 5:215-219
19. Brock MV, Hooker CM, Syphard JE, et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. J Thorac Cardiovasc Surg 2005;129:64-72
20. Vallières E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4:1049-1059
21. Schreiber D, Rineer J, Weedon J, et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: Should its role be reevaluated?. Cancer 2010;116:1350-1357
22. Badzio A, Kurowski K, Karnicka-Mlodkowska H, Jassem J. A retrospective comparative study of surgery followed by chemotherapy vs. nonsurgical management in limited-disease small cell lung cancer. Eur J Cardiothorac Surg 2004;26:183-188
23. Lim E, Belcher E, Yap YK, et al. The role of surgery in the treatment of limited disease small cell lung cancer: Time to reevaluate. J Thorac Oncol 2008; 3:1267-1271
24. Gaspar LE, McNamara EJ, Gay EG, et al. Small-cell lung cancer: Prognostic factors and changing treatment over 15 years. Clin Lung Cancer 2012;13:115-122